MorphoSys AG

NASDAQ: MOR · Real-Time Price · USD
18.96
0.45 (2.43%)
At close: Aug 02, 2024, 10:00 PM

MorphoSys Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
238.28M 278.27M 179.6M
Cost of Revenue
58.35M 48.62M 32.2M
Gross Profit
179.92M 229.65M 147.4M
Operating Income
-252.48M 162.26M -277.6M
Interest Income
18.32M 4.62M 96.6M
Pretax Income
-190.92M 17.52M -591.1M
Net Income
-189.73M -151.06M -514.5M
Selling & General & Admin
92.54M 90.22M 199.8M
Research & Development
283.61M 297.81M 225.2M
Other Expenses
968K 62.32M 1.8M
Operating Expenses
430.78M 450.36M 425M
Interest Expense
109.86M 116.52M 181.5M
Selling & Marketing Expenses
6.32M 6.33M 121.5M
Cost & Expenses
489.14M 498.98M 457.2M
Income Tax Expense
-1.19M 168.58M -76.6M
Shares Outstanding (Basic)
137.24M 136.62M 133.6M
Shares Outstanding (Diluted)
137.25M 136.62M 133.6M
EPS (Basic)
-1.38 -1.1 -3.85
EPS (Diluted)
-1.38 -1.1 -3.85
EBITDA
-97.74M 172.8M -179.2M
EBIT
-92.27M -136.46M -341.21M
Depreciation & Amortization
14.21M 10.41M 10.09M